Rinri Therapeutics starts transformational year at JP Morgan conference, discussing upcoming first-in-human trial in neural hearing loss
Press Release January 14th, 2025
Novel procedure for cell delivery in Rinri Therapeutics’ first clinical trial described in peer-reviewed publication
Press Release November 11th, 2024
Rinri Therapeutics latest article has been published by Otology and Neurotology.
Press Release July 2nd, 2024
Rinri Therapeutics Announces New Chair as It Approaches First Clinical Trial
Press Release April 29th, 2024
World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapies
Press Release December 13th, 2022
International research coalition verifies safe surgical access to the central core of the human cochlea for the very first time
Press Release November 9th, 2022
Rinri Therapeutics accelerates first regenerative cell therapy for hearing loss towards clinic with key senior hires and award of Innovation Passport
Press Releases May 3rd, 2022
Rinri Therapeutics Raises £10 million from Existing Investors and UK Future Fund to Advance its Novel Stem Cell Therapy to Restore Hearing Loss
Press Release April 20th, 2021
Ground-breaking study to measure hearing health
Press Release January 11th, 2021
Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss
Press Release May 20th, 2019